Ignite Creation Date:
2025-12-25 @ 12:45 AM
Ignite Modification Date:
2026-01-22 @ 3:23 PM
Study NCT ID:
NCT02184767
Status:
COMPLETED
Last Update Posted:
2021-11-12
First Post:
2014-07-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Assess the Safety and Pharmacokinetics of ADASUVE® at Doses of 2.5, 5, or 10 mg in Children and Adolescents (10 Through 17 Years of Age) With Any Condition Warranting Chronic Use of an Antipsychotic Medication
Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Organization: